itraconazole and Adult Spinal Muscular Atrophy

itraconazole has been researched along with Adult Spinal Muscular Atrophy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al Kotbi, N; Bergauer, T; Cleary, Y; Czech, C; Frances, N; Günther, A; Heinig, K; Jaber, B; Jordan, P; Khwaja, O; Kletzl, H; Marquet, A; Müller, L; Parkar, N; Poirier, A; Ratni, H; Sturm, S1

Trials

1 trial(s) available for itraconazole and Adult Spinal Muscular Atrophy

ArticleYear
A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier.
    British journal of clinical pharmacology, 2019, Volume: 85, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Azo Compounds; Cytochrome P-450 CYP3A Inhibitors; Double-Blind Method; Drug Interactions; Healthy Volunteers; Humans; Itraconazole; Male; Middle Aged; Muscular Atrophy, Spinal; Neuromuscular Agents; Pyrimidines; RNA Splicing; RNA, Messenger; Survival of Motor Neuron 2 Protein; Young Adult

2019